Actively Recruiting
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy
Led by Shanghai East Hospital · Updated on 2024-08-16
626
Participants Needed
1
Research Sites
64 weeks
Total Duration
On this page
Sponsors
S
Shanghai East Hospital
Lead Sponsor
P
Peking Union Medical College Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a randomized controlled and non-inferiority trial in comparison of the cognitive fusion targeted biopsy between the software-based fusion targeted biopsy in the detection rate of clinically significant cancer in men suspected to have a PCa.
CONDITIONS
Official Title
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- PSA level increased to 4-20 ng/ml and/or abnormal digital rectal exam
- Signed informed consent
You will not qualify if you...
- Acute or chronic prostatitis
- Contraindications to prostate biopsy
- Contraindications to MRI
- Other reasons making the participant unsuitable for this trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai East Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, China, 200120
Actively Recruiting
Research Team
B
Biming He, MD
CONTACT
H
Haifeng Wang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here